Corrigendum to “Evidence for Long-term Efficacy and Safety of Gene Therapy for Wiskott–Aldrich Syndrome in Preclinical Models”

Similar Items

• Evidence for Long-term Efficacy and Safety of Gene Therapy for Wiskott–Aldrich Syndrome in Preclinical Models
  od: Marangoni, Francesco, i dr.
  Izdano: (2009)
• Gene Therapy for Wiskott-Aldrich Syndrome: History, New Vectors, Future Directions
  od: Ferrua, Francesca, i dr.
  Izdano: (2020)
• Dendritic cell functional improvement in a preclinical model of lentiviral-mediated gene therapy for Wiskott-Aldrich syndrome
  od: Catucci, Marco, i dr.
  Izdano: (2011)
• The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function
  od: Locci, Michela, i dr.
  Izdano: (2009)
• Development of lentiviral gene therapy for Wiskott Aldrich syndrome
  od: Galy, Anne, i dr.
  Izdano: (2008)